Industry research

Behavioural Health and Child Development Services in India

Built from 1 source: 1 company-commissioned report · latest Sep 2026

Market size₹5,262.30 crore for the overall Indian NDD therapy market… [1]

Growth6.29% CAGR (CY26 to CY34) for the Indian ASD… [1]

Overview

The market for Neurodevelopmental Disorders (NDDs) in India represents a major, rapidly expanding, yet highly underserved healthcare vertical. The overall Indian NDD therapy market reached ₹5,262.30 crore (₹52,623 million) in CY2025. Within this, the market sizes for Autism Spectrum Disorder (ASD), ADHD, and Speech Disorders stood at ₹1,090.00 crore, ₹1,750.00 crore, and ₹166.00 crore respectively, and are projected to grow at strong CAGRs of 6.29%, 5.56%, and 11.76% through CY2034. [1]

Companies in this industry on FinMinutes

Rays of Belief IPO

Read these numbers with this in mind

Every source on this page so far is an industry report commissioned by a company for its public offer. The figures are the research firms', but each company chose the firm and the brief, so check how a market is defined before comparing it with figures from elsewhere.

Sources

Commissioned by a company CARE, Industry report in the offer document of Rays of BeliefOffer opened 1 Sep 2026 · p. 149, 150, 155, 174, 197Commissioned by Rays of Belief for its public offer.

Frequently asked questions

Where do these figures come from?

Built from 1 source: 1 company-commissioned report. Each figure carries its source number, which links to the full source list with dates and page references.

Figures are quoted from the sources listed above, with their dates and page references. They are not FinMinutes estimates and are not a recommendation about any security. All industries →